跳至主要内容
临床试验/NCT00608933
NCT00608933已完成3 期

CAM USE and Cancer

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家目标入组 1,356 人开始时间: 2008年6月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
1,356
试验地点
2
主要终点
Proportion of patients who report that the health provider discussed complimentary and alternative medicine (CAM) use

研究概览

简要总结

RATIONALE: Educating health providers on talking with cancer patients about complementary and alternative medicine (CAM) may help encourage health providers to talk more often with cancer patients about the use of CAM.

PURPOSE: This randomized phase III trial is studying how well an education intervention works in encouraging health providers to talk with cancer patients about the use of CAM.

详细描述

OBJECTIVES:

Primary

  • Examine the efficacy of an education intervention designed to increase the frequency with which health providers ask cancer patients about their use of complimentary and alternative medicine (CAM).

Secondary

  • Examine the frequency with which health providers ask about CAM use and referral for CAM use by health providers.
  • Evaluate whether personal CAM use among health providers is related to the frequency of asking patients about CAM use.
  • Assess the frequency and type of CAM use among patients diagnosed with cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Other
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Health provider meeting the following criteria:
  • •Has regular contact with cancer patients by initially talking with patients, taking their histories, and conveying pertinent information to their physician at a participating CCOP site
  • •Must be actively seeing patients at a participating University of Texas (UT) MD Anderson Cancer Center Community Clinical Oncology Program (CCOP) site
  • •Must not be employed at more than one participating CCOP site
  • •Not a temporary employee
  • •Patient of a health provider at a participating CCOP site meeting the following criteria:
  • •Current diagnosis of cancer including amyloidosis
  • •Diagnosed at least 1 week ago
  • •Finished treatment within the past 6 months
  • •Able to speak or read English
  • •No prior participation in this study at an earlier assessment
  • •PATIENT CHARACTERISTICS:
  • •Not specified
  • •PRIOR CONCURRENT THERAPY:
  • •Not specified

排除标准

  • 未提供

研究组 & 干预措施

Arm I (intervention)

Active Comparator

Health providers receive educational materials comprising a brief video about communicating with and providing guidance to patients regarding complimentary and alternative medicine (CAM) and a list of resources they can access to obtain information about herbs, CAM modalities, and drug/herb interactions. Approximately 2 weeks after the educational intervention, health providers receive a follow-up e-mail reminding them to ask patients about CAM use. The e-mail also includes a brief update regarding current research findings on CAM modalities and drug/herb interactions.

干预措施: educational intervention (Other)

Arm I (intervention)

Active Comparator

Health providers receive educational materials comprising a brief video about communicating with and providing guidance to patients regarding complimentary and alternative medicine (CAM) and a list of resources they can access to obtain information about herbs, CAM modalities, and drug/herb interactions. Approximately 2 weeks after the educational intervention, health providers receive a follow-up e-mail reminding them to ask patients about CAM use. The e-mail also includes a brief update regarding current research findings on CAM modalities and drug/herb interactions.

干预措施: questionnaire administration (Other)

Arm II (wait-list)

Other

Health providers are enrolled on a wait-list. After 2 months, the educational materials in arm I (educational intervention) are made available to the wait-list health providers.

干预措施: educational intervention (Other)

Arm II (wait-list)

Other

Health providers are enrolled on a wait-list. After 2 months, the educational materials in arm I (educational intervention) are made available to the wait-list health providers.

干预措施: questionnaire administration (Other)

结局指标

主要结局

Proportion of patients who report that the health provider discussed complimentary and alternative medicine (CAM) use

时间窗: Baseline to 2 months

The Complementary and Alternative Medicine Patient Survey administered to patients to assess personal use of CAM before and after the cancer diagnosis as well as the level of interaction with providers regarding CAM use. Baseline survey assessment at one week and follow up assessment at 2 months.

次要结局

  • Frequency with which health providers ask about CAM use and referral for CAM use by health providers(Baseline to 2 months)
  • Relationship between personal CAM use among health providers and frequency of asking patients about CAM use(Baseline to 2 months)
  • Frequency and type of CAM use among patients diagnosed with cancer(Up to 2 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验